| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| synonyms = citrovorum factor, 5-formyltetrahydrofolate
...
10 KB (1,413 words) - 17:58, 5 April 2024
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| synonyms = citrovorum factor, 5-formyltetrahydrofolate
...
10 KB (1,475 words) - 17:57, 5 April 2024
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
...ve reactive capability when bound to AdoCbl. For instance, AerR is another factor that uses AdoCbl to give off purple pigmentation. Additional examination of
...
4 KB (518 words) - 11:09, 6 April 2024
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
...ve reactive capability when bound to AdoCbl. For instance, AerR is another factor that uses AdoCbl to give off purple pigmentation. Additional examination of
...
4 KB (534 words) - 11:07, 6 April 2024
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| synonyms = citrovorum factor, 5-formyltetrahydrofolate
...
12 KB (646 words) - 19:00, 5 April 2024
...コーン]]、[[glycosaminoglycan/ja|グリコサミノグリカン]]、[[fibroblast/ja|線維芽細胞]]、[[growth factor/ja|成長因子]]および他の物質と組み合わせて使用されることもある。
多くの細菌やウイルスは、コラーゲンを破壊したり、その産生を阻害したりする酵素[[collagenase/ja|コラゲナーゼ]]などの[[virulence factor/ja|病原性因子]]を分泌する。
...
44 KB (1,385 words) - 18:39, 23 April 2024
...l surface receptor|receptor|受容体]]を標的としたもの、もう1つは痛みの治療薬として[[:en:nerve growth factor|神経成長因子]]を標的としたもの、そしてもう1つは癌の治療薬として[[:en:DLL4|デルタ様リガンド4]]を標的としたものであった。
* [[Wikipedia:Alprolix|Alprolix]] ([[Wikipedia:Factor IX|Factor IX]]), 血友病B用
...
55 KB (2,877 words) - 10:18, 4 January 2024
...matically higher than for conventional (pharmacological) medications. This factor has been particularly relevant since many biological medications are used t
*Blood factors ([[Factor VIII]] and [[Factor IX]])
...
29 KB (3,642 words) - 16:31, 3 January 2023
...a|ヘパリン]]、[[antiplatelet drug/ja|坑血小板薬]]、[[Fibrinolysis/ja|血栓溶解薬]]、[[Factor VIII/ja|抗血友病因子薬]]、[[Antihemorrhagic/ja|止血薬]]
...]、ソマトスタチン阻害剤、遺伝子組み換え[[interleukin/ja|インターロイキン]]、[[Granulocyte-colony 0pp0- factor/ja|G-CSF]]、[[erythropoietin/ja|エリスロポエチン]]
...
58 KB (1,845 words) - 17:09, 5 November 2023
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
...es]], [[alkene]] or [[alkyne]]. [[Steric hindrance]] is the major limiting factor in the synthesis of the {{chem|B|12}} coenzyme analogs. For example, no rea
...
15 KB (2,091 words) - 22:09, 6 April 2024
...orms of the bleeding disorder hemophilia, who are unable to produce factor VIII in quantities sufficient to support normal blood coagulation.<ref name="pmi
}}</ref> Before the development of recombinant factor VIII, the protein was obtained by processing large quantities of human blood fro
...
33 KB (4,424 words) - 16:33, 3 January 2023
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
...em|B|12}}の腸管吸収には3つの異なるタンパク質分子が必要である： [[haptocorrin/ja|ハプトコリン]]、[[intrinsic factor/ja|内在因子]]、[[transcobalamin II/ja|トランスコバラミンII]]である。
...
20 KB (1,053 words) - 10:13, 7 April 2024
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
...es]], [[alkene]] or [[alkyne]]. [[Steric hindrance]] is the major limiting factor in the synthesis of the {{chem|B|12}} coenzyme analogs. For example, no rea
...
16 KB (2,161 words) - 22:09, 6 April 2024
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| synonyms = Wills factor, FA, ''N''-(4-<nowiki/>{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]ami
...
53 KB (1,932 words) - 15:27, 5 April 2024
** Short chain (Type VIII, X)
...tion with [[silicone]]s, [[glycosaminoglycan]]s, [[fibroblast]]s, [[growth factor]]s and other substances.
...
36 KB (5,056 words) - 18:38, 23 April 2024
** Short chain (Type VIII, X)
...tion with [[silicone]]s, [[glycosaminoglycan]]s, [[fibroblast]]s, [[growth factor]]s and other substances.
...
36 KB (5,170 words) - 18:38, 23 April 2024
...equired blood plasma levels. Bioavailability is, therefore, a mathematical factor for each individual drug that influences the administered dose. It is possi
![[Coagulation factor]]s
...
44 KB (6,066 words) - 12:21, 15 November 2023
...gal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
In Western countries, chronic alcoholism is a risk factor for deficiency. Also at risk are older adults, persons with [[HIV/AIDS]] or
...
29 KB (4,040 words) - 11:14, 19 February 2024
...gal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
In Western countries, chronic alcoholism is a risk factor for deficiency. Also at risk are older adults, persons with [[HIV/AIDS]] or
...
30 KB (4,144 words) - 11:09, 19 February 2024
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
...修復に関与する核内酵素であるが、NAD+がない場合は細胞死につながる。D)神経保護作用のある[[brain-derived neurotrophic factor/ja|脳由来神経栄養因子]]またはその受容体[[tropomyosin receptor kinase B/ja|トロポミオシン受容体キナーゼB]]の
...
55 KB (2,081 words) - 15:30, 20 February 2024